REGENXBIO Inc.
$RGNX
Public valuation for REGENXBIO Inc. (RGNX). Fair value, signal, and key metrics — no sign-in required.
Current Price
$9.50
Fairly Valued
Fair Value Estimate
$8
🚧
Turnaround
Negative earnings but showing signs of recovery
Analyst Consensus
Target: $23.73
150% higher than current
Key Metrics
Market Cap
$627.1M
Operating Margin
27.1%
Revenue Growth
10.0%
Get free watchlist alerts
Join the waitlist for valuation updates on $RGNX and the rest of your watchlist.
Join the waitlistJoin the waitlist
Stay on this page to join — no sign-in required.